1,387
Views
9
CrossRef citations to date
0
Altmetric
Clinical Research

Recreational drug use at a major music festival: trend analysis of anonymised pooled urine

, , , , , , & show all
Pages 245-255 | Received 11 Apr 2017, Accepted 24 Jul 2017, Published online: 17 Aug 2017

References

  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2016 Trends And Delevopments. Publications Office of the European Union. 2016.
  • WHO. Essential medicines and health products. The facts on new psychoactive substances World Health Organization; 2016 [cited 2016 June 6]. Available from: http://www.who.int/medicines/access/controlled-substances/en/
  • Evans-Brown M, Gallegos A, Francis W, et al. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). Publications Office of the European Union. 2015.
  • Wood DM, Ceronie B, Dargan PI. Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs. QJM 2016;109:527–529.
  • Vevelstad M, Oiestad EL, Middelkoop G, et al. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int. 2012;219:151–157.
  • Liechti ME. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling. Swiss Med Wkly. 2015;145:w14043.
  • Andonian DO, Seaman SR, Josephson EB. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - A case series. Am J Emerg Med. 2017;35:940.
  • Ford BM, Tai S, Fantegrossi WE, et al. Synthetic Pot: Not Your Grandfather's Marijuana. Trends Pharmacol Sci. 2017;38:257–276.
  • Zawilska JB, Andrzejczak D. Next generation of novel psychoactive substances on the horizon - a complex problem to face. Drug Alcohol Depend. 2015;157:1–17.
  • Archer JR, Dargan PI, Lee HM, et al. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances. Clin Toxicol. 2014;52:160–165.
  • Archer JR, Dargan PI, Hudson S, et al. Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substances. QJM. 2013;106:147–152.
  • Stagelund S, Jans O, Nielsen K, et al. Medical care and organisation at the 2012 Roskilde Music Festival: a prospective observational study. Acta Anaesthesiol Scand. 2014;58:1086–1092.
  • Roskilde Festival. 2016 [cited November 2016]. Available from: http://www.roskilde-festival.dk/
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2015 Trends and Developments. Publications Office of the European Union. 2015.
  • Johnson-Davis KL, Sadler AJ, Genzen JR. A retrospective analysis of urine drugs of abuse immunoassay true positive rates at a national reference laboratory. J Anal Toxicol. 2016;40:97–107.
  • Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38:387–396.
  • Wiencek JR, Colby JM, Nichols JH. Rapid assessment of drugs of abuse. Adv Clin Chem. 2017;80:193–225.
  • Beck O, Carlsson S, Tusic M, et al. Laboratory and clinical evaluation of on-site urine drug testing. Scand J Clin Lab Invest. 2014;74:681–686.
  • Telving R, Hasselstrom JB, Andreasen MF. Targeted toxicological screening for acidic, neutral and basic substances in postmortem and antemortem whole blood using simple protein precipitation and UPLC-HR-TOF-MS. Forensic Sci Int. 2016;266:453–461.
  • Broseus J, Gentile N, Esseiva P. The cutting of cocaine and heroin: a critical review. Forensic Sci Int. 2016;262:73–83.
  • The Danish Health Authority. Illegal drugs in Denmark. 2015.
  • Ferle A/S. Cross-reactivity. 2016 [2017 June 22]. Available from: http://www.ferle.dk/krydsreaktion/
  • The Danish Health Authoritiy. [Narkotika på Gadeplan 2015] Drugs of abuse - Street report 2015. 2016.
  • The Danish Health Authority. 2017 [cited 2017 Feb 8]. Available from: www.medstat.dk
  • UNODC, Drug Characterization/impurity profiling, background and concepts, scientific section. 2001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.